Delivery Order SPE2DB22D2005-SPE2DB26FJDY7
- Not listed
- The Defense Logistics Agency awarded a $1,002.95 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Pimecrolimus 1% Cream in 30-gram units. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a $1,207.19 delivery order to AmerisourceBergen Drug Corp for Pimecrolimus 1% Cream in 30-gram units under a firm fixed-price contract with an ultimate completion date of September 23, 2025. This is a non-set-aside, competitively awarded delivery order executed as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's facility in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Pimecrolimus 1% Cream in a 30-gram quantity, valued at $20,510.86. This delivery order, issued on September 11, 2025, represents a firm fixed-price contract with an ultimate completion date of September 12, 2025. The contract carries no set-aside designation and was competitively awarded. AmerisourceBergen Drug Corp will perform the work at its corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Pimecrolimus 1% Cream in a 30-gram unit, with a contract value of $1,125.26. This is a firm fixed-price delivery order with no set-aside designation, awarded on July 31, 2025, with an ultimate completion date of August 1, 2025. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 2, 2025, for the supply of Pimecrolimus 1% Cream in 30-gram units, with a ceiling value of $1,484.50. This firm fixed-price delivery order, with an ultimate completion date of July 3, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made through competitive procurement with no set-aside designation....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,887.66 to AmerisourceBergen Drug Corp for the supply of Pimecrolimus 1% Cream in 30-gram units. This firm fixed price, non-competitive delivery order was issued on August 4, 2025, with an ultimate completion date of August 5, 2025. The pharmaceutical product will be delivered to the prime contractor's location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Pimecrolimus 1% Cream in 100-gram quantities, with a ceiling value of $2,181.45. The contract was competitively awarded without set-aside designation and is structured as a firm fixed-price delivery order with an ultimate completion date of August 25, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a competitive delivery order award from the Defense Logistics Agency (DLA) for Pimecrolimus 1% Cream in a 30-gram size with a ceiling value of $1,404.72. The contract is structured as a firm fixed price delivery order with an ultimate completion date of October 16, 2025, and was awarded on October 15, 2025. No set-aside designation was applied to this award, indicating it was...
- The Defense Logistics Agency awarded a delivery order valued at $2,031.34 to AmerisourceBergen Drug Corp for Pimecrolimus 1% Cream in 100-gram quantities. This non-competitive delivery order, issued on September 5, 2025, with an ultimate completion date of September 8, 2025, represents a firm fixed-price procurement executed under a child contract mechanism. The contractor, headquartered in Conshohocken, Pennsylvania, performed this order from its corporate office location. Pimecrolimus is a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,138.56 for Pimecrolimus 1% Cream 30GM, a topical immunosuppressant medication commonly used to treat inflammatory skin conditions. Awarded on August 28, 2025, with a completion date of August 29, 2025, this firm fixed-price delivery order represents a competitive award with no set-aside designation. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB26FJDY7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,480.02 to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Pimecrolimus 1% Cream in 30-gram quantities. This is a firm fixed-price delivery order with an ultimate completion date of October 20, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The award is a child contract under the company's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support agreement running through December 2026 that enables the company to supply pharmaceutical products and medical supplies globally to support military healthcare programs. This delivery order is issued under AmerisourceBergen Drug Corp's existing prime vendor relationship with the Defense Logistics Agency's Medical Supply Chain, which has consistently leveraged firm fixed-price delivery orders to procure a diverse portfolio of pharmaceuticals and medical supplies for federal health systems. As a major pharmaceutical distributor serving the Defense Health Agency and other government healthcare entities, AmerisourceBergen Drug Corp fulfills critical medical supply needs through its established IDC vehicle, which encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. The company's track record of competitive federal awards and its capacity to manage orders ranging from nominal amounts to those exceeding $45,000 demonstrates its capability to meet the federal medical procurement requirements reflected in this particular delivery order.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 10/17/25 |